Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novartis Expects FDA and EMA Approvals for Aimovig in 2018
Novartis Expects FDA and EMA Approvals for Aimovig in 2018
Novartis Expects FDA and EMA Approvals for Aimovig in 2018
Submitted by
admin
on February 21, 2018 - 9:47am
Source:
Yahoo/Market Realist
News Tags:
Novartis
FDA
EMA
drug approvals
Aimovig
migraines
Headline:
Novartis Expects FDA and EMA Approvals for Aimovig in 2018
Do Not Allow Advertisers to Use My Personal information
